sultilains

12/01/1977 - "Travase appears to be effective in the treatment of burn patients when used in this method."
01/01/1975 - "When applied topically and compared to its placebo experimentally in guinea pigs, Travase was associated with no damage to the epithelium of normal skin, slight damage to that of mechanically injuried (donor-site) skin, and total destruction of all the epithelium in skin subjected to severe but otherwise reversible burn injury. "
08/01/1980 - "Thirty-four hands in 24 patients with clinically diagnosed, deep second-degree burns have been treated for 24 hours, immediately after the burn with Sutilains bacterial enzymatic ointment. "
12/01/1977 - "Experience with the use of proteolytic enzyme (Travase) in burn patients."
12/01/1974 - "Travase: an effective proteolytic enzyme in the treatment of burns."

05/01/1975 - "The results of these experimental studies support our belief that clinical studies support our belief that clinical studies should now be initiated to test the therapeutic value of Travase as an adjunct to antibiotics in heavily contaminated wounds subjected to an unavoidable delay in treatment."
05/01/1975 - "Travase prolongs the period of effective topical antibiotic action for at least eight hours in experimental contaminated wounds. "
05/01/1975 - "Travase, the most potent fibrinolytic enzyme, is the most effective adjunct to delayed antibiotic therapy of contaminated wounds. "
11/30/2020 - "There was not enough evidence supporting the clinical values of Papain, Sutilains, Urea, etc. Surgical excision still remains the standard of care for burn wounds debridement. "
07/01/1976 - "In a preliminary study of 18 patients, sutilains (Travase) ointment exhibited rapid, effective debridement in the treatment of burns, decubiti, and traumatic wounds; peripheral vascular ulcerations responded less predictably. "

03/01/1988 - "was significantly elevated at 6 hours and until at least 2 weeks postburn; infection with Pseudomonas and use of the proteolytic debriding agent, Travase, each further elevated this activity; the plasma P.A. "
10/01/1974 - "The authors believe that rapid (hours) debridement accomplished by the combined use of chemical debriding and chemotherapeutic agents will obviate the possibility of any increase in infection, caused by the use of chemical agents for debridement, as reported for Paraenzyme(21) and Travase.(39,48) It is possible that the short term use of systemic antibiotics begun just before and continued during, and for a short time after, the rapid chemical debridement may prove useful for the prevention of infection, as appears to be the case for abdominal operations of the clean-contaminated and contaminated types."

01/01/1975 - "While not preventing this destruction of heat-injured epithelium by Travase, simultaneous use of topical silver sulfadiazine cream did reduce the weight loss and purulence associated with Travase therapy of burns. "

01/01/1987 - "Use of TENS for pain reduction in burn patients receiving Travase."